资讯

Targeted Oncology19 分钟
Novel CAR T Earns FDA RMAT Designation for Incurable Pediatric Brain Tumor
BCB-276 has earned regenerative medicine advanced therapy designation from the FDA in diffuse intrinsic pontine glioma, an ...
Targeted Oncology49 分钟
FDA Approves Retifanlimab, First Frontline Treatment for Advanced SCAC
With significant survival improvements seen, the FDA has granted approval to retifanlimab for the first-line treatment of ...